Pharmicell (005690) — Cash Flow Quality Index
Pharmicell (005690) has a Cash Flow Quality Index of 1.00x as of September 2025. Operating cash flow of ₩8.78 Billion exceeds net income of ₩8.78 Billion, indicating high earnings quality where cash backs reported profits. Explore 005690 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pharmicell Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Pharmicell across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Pharmicell to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Pharmicell (2019–2024)
Year-by-year earnings quality comparison for Pharmicell. For live market cap and the full company financial profile, see how much is Pharmicell worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.55x | ₩3.50 Billion | ₩6.33 Billion | ▼ -83.3% |
| 2023 | 3.30x | ₩11.81 Billion | ₩3.58 Billion | ▲ +244.7% |
| 2022 | 0.96x | ₩7.91 Billion | ₩8.26 Billion | ▲ +273.4% |
| 2021 | -0.55x | ₩-5.22 Billion | ₩9.45 Billion | ▼ -132.3% |
| 2020 | 1.71x | ₩8.98 Billion | ₩5.24 Billion | ▲ +9962.0% |
| 2019 | -0.02x | ₩-75.50 Million | ₩4.35 Billion | — |